Catalyst Wire Dossier Catalyst Wire Dossier

L-Ornithine L-Aspartate (LOLA)

L-ornithine-L-aspartate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for L-Ornithine L-Aspartate (LOLA), covering 2024-11-26 to 2024-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy [Phase 4]

See pricing